ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success Blog ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success Optimize ADC First-in-Human Dose Selection with model-informed strategies and exposure–response insights to design safer, more…Certara2026年3月3日
Phoenix Roadshow 2026 – Raleigh/Durham Live Events Phoenix Roadshow 2026 – Raleigh/Durham Certara2026年3月2日
Embracing Model-Informed Drug Discovery: The Path to Better Clinical Outcomes Blog Embracing Model-Informed Drug Discovery: The Path to Better Clinical Outcomes We cover the evidence of biosimulation improving clinical success rates, making the case for model-informed…Certara2026年2月27日
Phoenix Roadshow 2026 – Philadelphia Live Events Phoenix Roadshow 2026 – Philadelphia Certara2026年2月27日
Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit) On-Demand Webinar Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit) This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…Certara2026年2月27日
Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access Webinar Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access Danielle Pillsbury2026年2月23日
Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs) Webinar 最適な投与量、最適な治療結果:Model-Based Approaches for Antibody–Drug Conjugates (ADCs) Certara2026年2月23日
Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs) Webinar Strong starts, confident finishes: Optimizing first-in-human strategies for antibody–drug conjugates (ADCs) Certara2026年2月23日
Alternative parameters in NCA using Phoenix WinNonlin On-Demand Webinar Alternative parameters in NCA using Phoenix WinNonlin Learn how to enhance formulation evaluation using Phoenix tools to calculate advanced PK parameters beyond…Certara2026年2月23日